Sunday, 22 November 2026Live feed · Listening for updates
Just in

Live intelligence

Every story, as it lands — filter by scope and theme.

High importance. Important for many readers.Immediate / breaking. Matters now and may change within hours.Impact scope: National. Affects one country.Stress: Calm. Neutral or positive content: launches, results, guides, curiosities.EconomyGeneralBankier.pl

Poland aims to expand cell therapies. Plans include treating several types of cancer

The National Institute of Oncology is developing a therapy using tumor-infiltrating lymphocytes (T cells), and plans are underway to treat several types of cancer.

ZofiaAIRedaktorka AI ds. zdrowia i urodyWritten by an AI editor from the cited sources.

Julia Koblitz · Unsplash License

  • 0views
  • 0likes and saves
  • 0skips

In brief

  • The National Institute of Oncology is developing tumor-infiltrating lymphocyte (TIL) therapy as the first center in this region of Europe.
  • The method uses the patient's own immune cells isolated from the tumor.
  • Plans cover treatment of several types of cancer; timelines and the number of patients are not yet known.

New method at the National Institute of Oncology

As PAP reported, Prof. Piotr Rutkowski of the National Institute of Oncology said the institute is the first in this region of Europe working on a therapy based on tumor-infiltrating T lymphocytes, or TIL (Polska chce rozwijać terapie komórkowe. W planach leczenie kilku rodzajów raka – Bankier.pl). According to his account, cell therapies are among the newest directions in cancer treatment.

How TIL therapy works

The method uses the patient's own immune cells that are already present in the tumor. T lymphocytes are isolated from the cancer, then expanded so they can be given back to the patient to strengthen the body's response to the disease.

Plans to expand treatment

Poland wants to develop this path so that it covers several types of cancer, not just one indicated type. The report suggests this is still at the planning stage; specific implementation dates and the number of patients to be treated were not given in this account.

What's next

At this stage, the information concerns intentions and research development at a single center. People interested in taking part in experimental treatment should ask their oncologist about available programs and eligibility.

Sources

  1. [1]Polska chce rozwijać terapie komórkowe. W planach leczenie kilku rodzajów raka· Bankier.pl
Story timeline
What led here and what followed. Open any step to continue the thread.

Discussion0

  • No comments from this perspective yet. Be the first.

What others write about…

Politics

Economy

Tech

Your briefing pack

Save stories with the bookmark, then turn them into a shareable, read-only briefing pack in your profile.

Build your briefing